HII Declares Quarterly Dividend

HII Declares Quarterly Dividend GlobeNewswire July 30, 2025 NEWPORT NEWS, Va., July 30, 2025 (GLOBE NEWSWIRE) — HII (NYSE: HII) announced today that its Board of Directors has declared a quarterly cash dividend of $1.35 per share, payable on September 12, 2025, to shareholders of record as of the close of business on Aug. 29, […]

Blue Foundry Bancorp Reports Second Quarter 2025 Results

Blue Foundry Bancorp Reports Second Quarter 2025 Results GlobeNewswire July 30, 2025 RUTHERFORD, N.J., July 30, 2025 (GLOBE NEWSWIRE) — Blue Foundry Bancorp (NASDAQ:BLFY) (the “Company”), the holding company for Blue Foundry Bank (the “Bank”), today reported a net loss of $2.0 million, or $0.10 per diluted common share, for the three months ended June

Flow Sciences Announces New Office in North Carolina’s Research Triangle Park

Flow Sciences, a global leader in advanced containment solutions, today announced the opening of a new office in the Research Triangle area of North Carolina. The exact location will be announced soon. This strategic expansion will feature a state-of-the-art product showroom, training facilities, and consultative design center to better serve both existing and prospective clients.

South Dakota Partners with Avel eCare to Launch the First-of-Its-Kind Continuing Education (CE) Program for EMS Teams Using Real-Time Telemedicine Support

SIOUX FALLS, SD / ACCESS Newswire / July 30, 2025 / The South Dakota Department of Health in partnership with Avel eCare, a national leader in innovative telemedicine solutions, is proud to introduce a new and uniquely impactful continuing education (CE) credit opportunity for emergency medical services professionals. Beginning August 25, EMS personnel who engage

Preferred Hotels & Resorts Partners with DayBlink GPO to Centralize Distribution and Unlock Greater Control for Member Hotels

NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) — Preferred Hotels & Resorts, the world's largest independent hotel brand, today announced a strategic partnership with DayBlink GPO (Global Procurement Organization) to support its member hotels in gaining greater control over their distribution ecosystem and reducing reliance on higher-cost channels. Phase one of the collaboration introduces chain-level

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

(NASDAQ:SPRC),(NASDAQ:CMND), TEL AVIV, Israel, July 30, 2025 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that its collaboration with Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind”) has led to the

LAZR Class Action Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Luminar Technologies, Inc. Class Action

Robbins LLPreminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Luminar Technologies, Inc. (NASDAQ: LAZR) securities between March 20, 2025 and May 14, 2025. Luminar purports to be a technology company specializing in advanced LiDAR hardware and software solutions for vehicles. https://mma.prnewswire.com/media/1321386/Robbins_LLP_Logo.jpg For more information, submit a

Preferred Hotels & Resorts Partners with DayBlink GPO to Centralize Distribution and Unlock Greater Control for Member Hotels

Preferred Hotels & Resorts Partners with DayBlink GPO to Centralize Distribution and Unlock Greater Control for Member Hotels GlobeNewswire July 30, 2025 NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) — Preferred Hotels & Resorts, the world's largest independent hotel brand, today announced a strategic partnership with DayBlink GPO (Global Procurement Organization) to support its member

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease GlobeNewswire July 30, 2025 TEL AVIV, Israel, July 30, 2025 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and

Scroll to Top